preliminary results of a phase ii study of fedratinib in patients with mds/mpn and cnl
Published 7 months ago • 108 plays • Length 2:03Download video MP4
Download video MP3
Similar videos
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:42
results of phase i/ii study of epcoritamab r-dhax/c in patients with r/r dlbcl eligible for autosct
-
1:17
phase ii study of tosedostat in mds
-
3:52
a phase ii study evaluating the safety and efficacy of olutasidenib in patients with r/r midh1 aml
-
20:18
surgical phase 2
-
23:23
identifying and treating high-risk patients in 2023
-
1:56
promising targets beyond flt3 in aml: idh1/2 & menin
-
2:11
update on phase i/ii study of azacitidine, venetoclax and gilteritinib in patients with flt3 aml
-
2:42
results from a phase i study of cc-98633 in r/r myeloma
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
1:56
updated results of phase i/ii bruin study: pirtobrutinib in covalent btk inhibitor pretreated mcl
-
2:04
phase i/ii study of a novel bet inhibitor, bms-986158, alone & with ruxolitinib or fedratinib in mf
-
3:56
results of the phase ii titan study of caplacizumab in patients with attp
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
3:13
preliminary results from the frida study: iadademstat and gilteritinib in flt3-mutated r/r aml
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
1:35
phase i study of plx51107, a novel bet inhibitor, in combination with azacitidine in r/r mds and aml
-
1:16
using rwd to evaluate the use of fedratinib as a potential bridge to hsct in patients with mf
-
2:04
introducing a phase ib/ii trial to evaluate tasquinimod for the treatment of myelofibrosis
-
1:06
fedratinib: mpn-associated myelofibrosis
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
4:48
an insight into the management of cytopenias in mf